# Eswatini Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Eswatini HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Eswatini (SWZ)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $12.0M
- Products: 30
- Buyer markets: 30
- Average CAGR: +24.3%
- Global sector size: $393.4B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $267.1B | $1.6M | $90.8B | -0.0% | 22 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $27.1B | $3.8M | $19.0B | +12.6% | 11 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $9.0B | $4.9M | $11.3B | -7.6% | 4 | +0.1% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $26.2B | $153.7K | $10.4B | +24.3% | 8 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $16.4B | $374.7K | $7.0B | +124.5% | 7 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $10.6B | $440.6K | $5.6B | -12.2% | 5 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $7.1B | $1.4K | $3.8B | -24.8% | 2 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $8.1B | $293.3K | $3.2B | +187.7% | 3 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $4.2B | $37.8 | $2.4B | -29.9% | 3 | +0.0% |
| HS 290919 - Ethers: acyclic, and their halogenated, sulphonated, nitrated or nitrosated derivatives, other than diethyl ether | $1.5B | $24.0K | $2.1B | +92.9% | 1 | +0.0% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $3.0B | $8.4K | $1.8B | -11.0% | 3 | +0.0% |
| HS 284390 - Inorganic or organic compounds: of precious metals (excluding gold and silver), whether or not chemically defined, amalgams of precious metals | $892.9M | $6.5K | $1.7B | -19.3% | 1 | +0.0% |
| HS 381512 - Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included | $1.4B | $4.3K | $1.7B | +0.1% | 1 | +0.0% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $1.9K | $1.4B | +19.7% | 1 | +0.0% |
| HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $1.2K | $1.1B | -2.8% | 1 | +0.0% |
| HS 290250 - Cyclic hydrocarbons: styrene | $768.8M | $13.7K | $1.1B | +64.3% | 1 | +0.0% |
| HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $99.4K | $989.9M | +7.3% | 1 | +0.0% |
| HS 340130 - Organic surface-active products and preparations for washing the skin, in the form of liquid or cream and put up for retail sale, whether or not containing soap | $1.1B | $2.9K | $889.0M | +67.9% | 2 | +0.0% |
| HS 290243 - Cyclic hydrocarbons: p-xylene | $820.5M | $14.6K | $838.7M | +74.8% | 1 | +0.0% |
| HS 281820 - Aluminium oxide: other than artificial corundum | $656.5M | $22.8 | $716.5M | +27.9% | 1 | +0.0% |
| HS 290110 - Acyclic hydrocarbons: saturated | $440.6M | $14.0K | $651.3M | +32.5% | 1 | +0.0% |
| HS 340600 - Candles, tapers and the like | $1.0B | $36.3K | $640.8M | -14.6% | 1 | +0.0% |
| HS 290321 - Unsaturated chlorinated derivatives of acyclic hydrocarbons: vinyl chloride (chloroethylene) | $496.5M | $7.9K | $585.0M | +67.9% | 1 | +0.0% |
| HS 290531 - Alcohols: acyclic, diols: ethylene glycol (ethanediol) | $613.4M | $6.6K | $571.0M | -29.5% | 1 | +0.0% |
| HS 291539 - Acids: saturated acyclic monocarboxylic acids: esters of acetic acid n.e.s. in item no. 2915.3 | $407.2M | $2.1K | $566.9M | -24.4% | 1 | +0.0% |
| HS 380110 - Graphite: artificial | $322.5M | $218.5K | $541.5M | +37.4% | 1 | +4.2% |
| HS 292429 - Cyclic amides (including cyclic carbamates) and their derivatives: other than the derivatives and salts of ureines, 2-acetamidobenzoic acid (N-acetylanthancillic acid), and ethinamate S | $428.3M | $10.2K | $479.1M | +180.6% | 1 | +0.0% |
| HS 293090 - Organo-sulphur compounds: n.e.s. in heading no. 2930 | $318.2M | $11.3K | $449.4M | +43.9% | 1 | +0.0% |
| HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $397.1M | $117.9 | $433.9M | -19.4% | 1 | +0.0% |
| HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $433.4M | $78.5 | $428.0M | -17.6% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $40.8B calculated opportunity across 10 products.
- Switzerland, Liechtenstein (CHE): $27.7B calculated opportunity across 1 products.
- Mexico (MEX): $14.0B calculated opportunity across 10 products.
- China (CHN): $12.3B calculated opportunity across 6 products.
- Canada (CAN): $10.2B calculated opportunity across 7 products.
- United Kingdom (GBR): $10.0B calculated opportunity across 7 products.
- Germany (DEU): $8.4B calculated opportunity across 4 products.
- India (IND): $7.6B calculated opportunity across 9 products.
- Belgium (BEL): $7.0B calculated opportunity across 1 products.
- France (FRA): $5.7B calculated opportunity across 4 products.
- Ireland (IRL): $3.8B calculated opportunity across 2 products.
- Japan (JPN): $3.7B calculated opportunity across 1 products.

## Growth stars

- HS 300215: +187.7% average CAGR, $3.2B calculated opportunity.
- HS 292429: +180.6% average CAGR, $479.1M calculated opportunity.
- HS 382200: +124.5% average CAGR, $7.0B calculated opportunity.
- HS 290919: +92.9% average CAGR, $2.1B calculated opportunity.
- HS 290243: +74.8% average CAGR, $838.7M calculated opportunity.
- HS 340130: +67.9% average CAGR, $889.0M calculated opportunity.
- HS 290321: +67.9% average CAGR, $585.0M calculated opportunity.
- HS 290250: +64.3% average CAGR, $1.1B calculated opportunity.
- HS 293090: +43.9% average CAGR, $449.4M calculated opportunity.
- HS 380110: +37.4% average CAGR, $541.5M calculated opportunity.

## Diversification opportunities

- HS 300490: 22 buyer markets, $90.8B calculated opportunity.
- HS 382499: 11 buyer markets, $19.0B calculated opportunity.
- HS 330499: 8 buyer markets, $10.4B calculated opportunity.
- HS 382200: 7 buyer markets, $7.0B calculated opportunity.
- HS 330300: 5 buyer markets, $5.6B calculated opportunity.
- HS 330210: 4 buyer markets, $11.3B calculated opportunity.
- HS 300215: 3 buyer markets, $3.2B calculated opportunity.
- HS 300290: 3 buyer markets, $2.4B calculated opportunity.
- HS 293399: 3 buyer markets, $1.8B calculated opportunity.
- HS 293499: 2 buyer markets, $3.8B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.